Impact of delirium on decision-making capacity after hematopoietic stem-cell transplantation

Psychosomatics

Volumn 51, Issue 4, 2010, Pages 320-329

  Zaubler, Thomas ^a   Fann, Jesse R ^a   Roth Roemer, Sari ^a   Katon, Wayne J ^a   Bustami, Rami ^a   Syrjala, Karen L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DELIRIUM; DELIRIUM RATING SCALE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MACARTHUR COMPETENCE ASSESSMENT TOOL; MALE; MEDICAL DECISION MAKING; MEMORIAL DELIRIUM ASSESSMENT SCALE; MYELOABLATIVE CONDITIONING; RATING SCALE; SCORING SYSTEM; DECISION MAKING; FOLLOW UP; MENTAL CAPACITY; MIDDLE AGED; PROSPECTIVE STUDY; PSYCHOLOGY;

ADULT; DECISION MAKING; DELIRIUM; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MENTAL COMPETENCY; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 77955607644     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1176/appi.psy.51.4.320     Document Type: Article

References (56)

1. Appelbaum P, Lidz C, Meisel A: Informed Consent: Legal Theory and Clinical Practice. New York, Oxford Univ. Press, 1987
2. Grisso T, Appelbaum PS: The MacArthur Treatment Competence Study, III: abilities of patients to consent to psychiatric and medical treatments. Law Hum Behav 1995; 19:149-174
3. Peper M, Steinvorth S, Schraube P, et al: Neurobehavioral toxicity of total body irradiation: a follow-up in long-term survivors. Int J Radiat Oncol Biol Phys 2000; 46:303-311 (Pubitemid 30067779)
4. Pless M, Zivkovic SA: Neurologic complications of transplantation. Neurologist 2002; 8:107-120
5. Sostak P, Padovan CS, Yousry TA, et al: Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology 2003; 60:842-848 (Pubitemid 36297371)
6. Syrjala KL, Dikmen S, Langer SL, et al: Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant. Blood 2004; 104:3386-3392 (Pubitemid 39507163)
7. Bartynski WS, Zeigler ZR, Shadduck RK, et al: Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation. AJNR Am J Neuroradiol 2004; 25:261-269
8. Trullemans F, Grignard F, Van Camp B, et al: Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation. Eur J Haematol 2001; 67:94-99 (Pubitemid 33010384)
9. Shah AK: Cyclosporine-A neurotoxicity among bone marrow transplant recipients. Clin Neuropharmacol 1999; 22:67-73
10. Weinrich S, Sarna L: Delirium in the older person with cancer. Cancer 1994; 74:2079-2091
11. Stiefel F, Holland J: Delirium in cancer patients. Int Psychogeriatr 1991; 3:333-336
12. Stiefel F, Fainsinger R, Bruera E: Acute confusional states in patients with advanced cancer. J Pain Symptom Manage 1992; 7:94-98
13. Massie MJ, Holland J, Glass E: Delirium in terminally-ill cancer patients. Am J Psychiatry 1983; 140:1048-1050
14. Minagawa H, Uchitomi Y, Yamawaki S, et al: Psychiatric morbidity in terminally-ill cancer patients: a prospective study. Cancer 1996; 78:1131-1137 (Pubitemid 26284881)
15. Gagnon P, Allard P, Masse B, et al: Delirium in terminal cancer: a prospective study using daily screening, early diagnosis, and continuous monitoring. J Pain Symptom Manage 2000; 19:412-426 (Pubitemid 30447367)
16. Lawlor PG, Gagnon B, Mancini IL, et al: Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med 2000; 160:786-794 (Pubitemid 30165239)
17. Fann JR, Roth-Roemer S, Burington BE, et al: Delirium in patients undergoing hematopoietic stem cell transplantation. Cancer 2002; 95:1971-1981
18. Fann JR, Alfano CM, Burington BE, et al: Clinical presentation of delirium in patients undergoing hematopoietic stem-cell transplantation. Cancer 2005; 103:810-820
19. Caraceni A, Nanni O, Maltoni M, et al: Impact of delirium on the short-term prognosis of advanced cancer patients: Italian Multicenter Study Group on Palliative Care. Cancer 2000; 89:1145-1149
20. Coyle N, Breitbart W, Weaver S, et al: Delirium as a contributing factor to "crescendo" pain: three case reports. J Pain Symptom Manage 1994; 9:44-47
21. Gagnon B, Lawlor PG, Mancini IL, et al: The impact of delirium on the circadian distribution of breakthrough analgesia in advanced cancer patients. J Pain Symptom Manage 2001; 22:826-833 (Pubitemid 32884375)
22. Tuma R, DeAngelis LM: Altered mental status in patients with cancer. Arch Neurol 2000; 57:1727-1731
23. Ljubisavljevic V, Kelly B: Risk factors for development of delirium among oncology patients. Gen Hosp Psychiatry 2003; 25:345-352 (Pubitemid 37102942)
24. Breitbart W, Gibson C, Tremblay A: The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics 2002; 43:183-194 (Pubitemid 34522528)
25. Hallberg IR: Impact of delirium on professionals. Dement Geriatr Cogn Disord 1999; 10:420-425
26. Fann JR, Alfano CM, Roth-Roemer S, et al: Impact of delirium on cognition, distress, and health-related quality of life after hematopoietic stem-cell transplantation. J Clin Oncol 2007; 25:1223-1231 (Pubitemid 46640568)
27. Sullivan MD, Youngner SJ: Depression, competence, and the right to refuse life-saving medical treatment. Am J Psychiatry 1994; 151:971-978
28. Taub HA: Informed consent, memory, and age. Gerontologist 1980; 20:686-690
29. Bursztajn HJ, Harding HP Jr, Gutheil TG, et al: Beyond cognition: the role of disordered affective states in impairing competence to consent to treatment. Bull Am Acad Psychiatry Law 1991; 19:383-388
30. Auerswald KB, Charpentier PA, Inouye SK: The informed-consent process in older patients who developed delirium: a clinical epidemiologic study. Am J Med 1997; 103:410-418
31. Fan E, Shahid S, Kondreddi VP, et al: Informed consent in the critically ill: a two-step approach incorporating delirium screening. Crit Care Med 2008; 36:94-99
32. Fogel BS, Mills MJ, Landen JE: Legal aspects of the treatment of delirium. Hosp Community Psychiatry 1986; 37:154-158
33. Trzepacz PT, Baker RW, Greenhouse J: A symptom rating scale for delirium. Psychiatry Res 1988; 23:89-97
34. Trzepacz PT: The Delirium Rating Scale. Its use in consultation- liaison research. Psychosomatics 1999; 40:193-204
35. Breitbart W, Rosenfeld B, Roth A, et al: The Memorial Delirium Assessment Scale. J Pain Symptom Manage 1997; 13:128-137
36. Lawlor PG, Nekolaichuk C, Gagnon B, et al: Clinical utility, factor analysis, and further validation of The Memorial Delirium Assessment Scale in patients with advanced cancer: assessing delirium in advanced cancer. Cancer 2000; 88:2859-2867 (Pubitemid 30417951)
37. Grassi L, Caraceni A, Beltrami E, et al: Assessing delirium in cancer patients: the Italian versions of the Delirium Rating Scale and the Memorial Delirium Assessment Scale. J Pain Symptom Manage 2001; 21:59-68 (Pubitemid 32149664)
38. Derogatis LR: The SCL-90-R, Baltimore, MD, Clinical Psychometrics Research, 1975
39. McNair D, Lorr M, Droppelman L: EITS Manual for the Profile of Mood States. San Diego, CA, Educational and Industrial Testing Service, 1971
40. Cella DF, Jacobsen PB, Orav EJ, et al: A brief POMS measure of distress for cancer patients. J Chronic Dis 1987; 40:939-942
41. Stuss DT, Knight RT: Principles of Frontal Lobe Function. New York, Oxford Univ. Press, 2002
42. Grigsby J, Kaye K, Robbins LJ: Reliabilities, norms, and factor structure of the Behavioral Dyscontrol Scale. Percept Mot Skills 1992; 74:883-892
43. Reitan RM, Wolfson D: The Halstead-Reitan Neuropsychological Test Battery: theory and clinical interpretation. Tucson, AZ, Neuropsychology Press, 1993
44. Wechsler D: WAIS-R Manual. New York, The Psychological Corporation, 1981
45. Benedict R, Schretlen D, Groninger L, et al: Hopkins Verbal Learning Test, Revised: normative data and analysis of interform and test-retest reliability. Clin Neuropharmacol 1998; 12:43-55
46. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State:" a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
47. Grisso T, Appelbaum PS, Hill-Fotouhi C: The MacCAT-T: a clinical tool to assess patients' capacities to make treatment decisions. Psychiatr Serv 1997; 48:1415-1419 (Pubitemid 27465168)
48. Grisso T, Appelbaum PS: Comparison of standards for assessing patients' capacities to make treatment decisions. Am J Psychiatry 1995; 152:1033-1037
49. Raymont V, Buchanan A, David AS, et al: The interrater reliability of mental capacity assessments. Int J Law Psychiatry 2007; 30:112-117 (Pubitemid 46329118)
50. Cairns R, Maddock C, Buchanan A, et al: Reliability of mental capacity assessments in psychiatric inpatients. Br J Psychiatry 2005; 187:372-378 (Pubitemid 41442391)
51. Lapid MI, Rummans TA, Pankratz VS, et al: Decisional capacity of depressed elderly to consent to electroconvulsive therapy. J Geriatr Psychiatry Neurol 2004; 17:42-46
52. Kim SY, Caine ED: Utility and limits of the Mini-Mental State Exam in evaluating consent capacity in Alzheimer's disease. Psychiatr Serv 2002; 53:1322-1324
53. Casarett DJ, Karlawish JH, Hirschman KB: Identifying ambulatory cancer patients at risk of impaired capacity to consent to research. J Pain Symptom Manage 2003; 26:615-624
54. Fisch M, Unverzagt F, Hanna M, et al: Information preferences, reading ability, and emotional changes in outpatients during the process of obtaining informed consent for autologous bone-marrow transplantation. J Cancer Educ 1998; 13:71-75 (Pubitemid 28299819)
55. Kaplan SH, Greenfield S, Gandek B, et al: Characteristics of physicians with participatory decision-making styles. Ann Intern Med 1996; 124:497-504 (Pubitemid 26070116)
56. Drane JF: Competency to give an informed consent: a model for making clinical assessments. JAMA 1984; 252:925-927